Skip to main navigation
Tenaya Therapeutics
  • Careers at Tenaya
  • Contact Us
  • Leadership
  • Our Science
    • Platforms
    • Capabilities
    • Collaborations
    • Publications & Presentations
  • Our Programs
    • Pipeline
    • Programs
  • Patients
    • Elevating Patient Voices
    • Advocacy at Tenaya
    • Clinical Studies
    • Gene Therapy for Cardiomyopathies
    • Advocacy Partners
  • Investors
    • News & Events
      • Press Releases
      • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • HCP Resource Center
    • Genetic Medicine Primer
      • About Gene Therapy
    • TN-201 for MYBPC3– associated HCM
      • Hypertrophic Cardiomyopathy and Genetics
      • How TN-201 Works
      • MyPEAK-1 Phase 1b/2 Clinical Trial
      • Tenaya’s Non-interventional Studies for MYBPC3 HCM
      • Webinars
      • FAQ’s
    • TN-401 for PKP2– associated ARVC
      • ARVC and Genetics
      • How TN-401 works
      • RIDGE-1 Phase 1b Clinical Trial
      • Tenaya’s Non-interventional Study for PKP2-Associated ARVC
      • FAQ’s

Investor Portal

Presentations
Tenaya Therapeutics Corporate Presentation 7.6 MB
Upcoming Events
There are no upcoming events available at this time.
Past Events
Canaccord Genuity 46th Annual Growth Conference
Aug 11, 2026 at 12:30 PM EDT
Click here for webcast
Jefferies Global Healthcare Conference
Jun 4, 2026 at 3:10 PM EDT
Click here for webcast
Jefferies Global Healthcare Conference Presentation 5.5 MB
Interim Data from the MyPEAK-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy
Jun 3, 2026 at 8:00 AM EDT
Click here for webcast
Interim Data from the MyPEAK-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy Presentation 1.4 MB
Data from RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 in Adults with PKP2-associated ARVC Presented at ASGCT 2026
May 15, 2026 at 10:30 AM EDT
Click here for webcast
Data from RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 in Adults with PKP2-associated ARVC Presented at ASGCT 2026 Presentation 6.1 MB
Leerink Global Healthcare Conference
Mar 9, 2026 at 1:00 PM EDT
Click here for webcast
Measuring Protein Expression in Cardiac Gene Therapy - KOL Webcast Event
Aug 26, 2025 from 11:30 AM to 1:00 PM EDT
Register here
Measuring Protein Expression in Cardiac Gene Therapy - KOL Webcast Event Presentation 2.8 MB
RSS Feeds
Email Alerts
Contact IR
Print

Privacy Policy | Cookie Policy | Terms of Use | Community Guidelines
© 2026 Tenaya Therapeutics. All rights reserved.